Paylocity Holding Corp (PCTY) insider transactions: Andrew Cappotelli, Senior Vice President of Operations, reported two dispositions of common stock under an approved 10b5-1 trading plan adopted on February 25, 2025. On 09/02/2025 he disposed of 52 shares at $179.23 each, leaving 22,904 shares beneficially owned. On 09/03/2025 he sold an additional 77 shares at $173.68 each, leaving 22,827 shares beneficially owned.
The filing identifies the reporting person as an officer and shows the trades were executed pursuant to a 10b5-1 plan, indicating the sales were prearranged rather than ad hoc. No derivative transactions or other compensatory equity grants are reported.
Paylocity insider sale notice: This Form 144 shows a proposed sale of 77 common shares by an insider through Morgan Stanley Smith Barney, with an aggregate market value of $13,439.58 and an approximate sale date of 09/03/2025. The filer reports the shares were acquired as restricted stock units on 09/01/2025 and payment was recorded on the same date. The issuer has 55,161,627 shares outstanding, placing this proposed sale at an immaterial scale relative to total outstanding stock. The filing also discloses two prior 10b5-1 sales by the same person in 06/2025 and 08/2025 totaling 3,589 shares for gross proceeds of $636,341.62.
Paylocity Holding Corp insider Andrew Cappotelli, Sr. Vice President, Operations, reported a sale of 1,872 shares of Paylocity common stock on 08/20/2025 at a price of $177.82 per share. After the reported transaction, Cappotelli beneficially owns 22,956 shares directly. The filing indicates the sale was executed under an approved 10b5-1 trading plan adopted by the reporting person on February 25, 2025. The Form 4 was signed by attorney-in-fact Kris Kang on 08/22/2025. No derivative transactions or other securities classes were reported.
Paylocity Holding Corp (PCTY) insider filing: Senior Vice President Sales Joshua Scutt reported multiple open-market sales of Paylocity common stock executed on 08/20/2025 under an approved 10b5-1 plan adopted December 12, 2024. The Form 4 lists three dispositions of 880, 958, and 1,763 shares at weighted-average prices of approximately $178.55, $179.58, and $180.78, respectively. Following these transactions the reported beneficial ownership figures shown are 54,627, 53,669, and 51,906 shares. The filing also notes 118 shares are owned by the reporting person’s father-in-law with investment power held by the reporting person’s spouse.
Paylocity Holding Corp (PCTY) officer Nicholas Rost reported two open-market sales of common stock executed under an approved 10b5-1 trading plan adopted November 20, 2024. On 08/19/2025 he sold 378 shares at $177.58 per share and on 08/20/2025 he sold 130 shares at $177.82 per share. The Form 4 indicates beneficial ownership of 9,508 shares following the first reported sale and 9,378 shares following the second. The filing is signed by an attorney-in-fact on 08/21/2025 and includes an explicit note that the sales were made pursuant to the 10b5-1 plan.
Paylocity Holding Corp (PCTY) Chief Financial Officer Glenn Ryan reported sales of common stock executed on 08/19/2025 under an approved 10b5-1 plan adopted November 20, 2024. The Form 4 shows three sell transactions totaling 1,303 shares at weighted-average prices reported as $177.4 and $178.89, with an individual sale at $179.49; prices in the footnotes ranged from $177.14 to $179.43. After these transactions the reporting person beneficially owned 80,410 shares. The filing was signed by attorney-in-fact Kris Kang on 08/21/2025.
Form 144 notice for Paylocity Holding Corporation (PCTY): a proposed sale of 3,601 shares of common stock is being reported. The shares were acquired as PSUs/RSUs on 08/15/2024 from the issuer and are scheduled for approximate sale on 08/20/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The filing states an aggregate market value of $641,122.04 and shows 55,161,627 shares outstanding for the class. The filer also disclosed a prior sale by Joshua Scutt of 548 shares on 06/04/2025 for $105,818.80. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.
Paylocity Holding Corporation (PCTY) Form 144 notifies the proposed sale of 1,872 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $333,290.88 and approximately 55,161,627 shares outstanding. The shares were acquired as PSUs/RSUs on 08/15/2025 from the issuer and the planned sale date is 08/20/2025. The filing also discloses recent 10b5-1 sales by Andrew Cappotelli totaling 1,727 shares in June 2025 for gross proceeds of $305,365.98 (1,717 shares on 06/23/2025 for $303,462.58 and 10 shares on 06/03/2025 for $1,903.40). The filer certifies no undisclosed material adverse information and notes potential reliance on a Rule 10b5-1 trading plan.
Paylocity Holding Corporation (PCTY) filed a Form 144 reporting a proposed sale of 1,303 common shares on 08/19/2025 through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $232,168.54. The filing shows these shares were acquired as restricted stock units from the issuer on 08/15/2025, and payment/settlement is recorded on that same date. The filer certifies no undisclosed material adverse information and indicates there were no other sales in the past three months.
This notice is a standard Rule 144 disclosure describing the planned sale, the acquisition method, and broker details; it does not provide financial results, forward guidance, or other operational metrics.
Paylocity Holding Corporation (PCTY) filing reports a Rule 144 notice that 508 restricted common shares granted as restricted stock units were acquired on 08/15/2025 and are proposed for sale through Morgan Stanley Smith Barney LLC on 08/19/2025. The filing lists an aggregate market value of $90,515.44 for the shares and shows 55,161,627 shares outstanding, indicating the proposed sale represents a de minimis portion of total outstanding stock. The filer reports no other sales in the past three months and states the usual representation that they have no undisclosed material adverse information.